Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004
Published online before print September 9, 2004, doi: 10.1161/01.RES.0000144175.70140.8c
A more recent version of this article appeared on October 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/7/700    most recent
01.RES.0000144175.70140.8cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tavener, S. A.
Right arrow Articles by Kubes, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavener, S. A.
Right arrow Articles by Kubes, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Contractile function
Right arrow Other heart failure
Right arrow Infectious endocarditis
Right arrow Animal models of human disease

Submitted on January 7, 2004
Revised on July 27, 2004
Accepted on August 26, 2004

Immune Cell TLR4 Is Required for Cardiac Myocyte Impairment During Endotoxemia

Samantha A. Tavener ; Elizabeth M. Long ; Stephen M. Robbins ; Krista M. McRae ; Holly Van Remmen ; and Paul Kubes *

From the Immunology Research Group, Department of Physiology and Biophysics (S.A.T., K.M.M., P.K.), Departments of Oncology and Biochemistry and Molecular Biology (E.M.L., S.M.R.), University of Calgary Medical Centre, Calgary, Alberta, Canada; Departments of Cellular and Structural Biology (H.V.R.), University of Texas Health Science Center, San Antonio.

* To whom correspondence should be addressed. E-mail: pkubes{at}ucalgary.ca.

The aim of this study was to investigate the importance of Toll-like Receptor 4 (TLR4) signaling on cardiac myocytes versus immune cells in lipopolysaccharide (LPS)-induced cardiac dysfunction. Cardiac myocytes isolated from LPS-treated C57Bl/6 mice showed reduced contractility and calcium transients as compared with myocytes from untreated mice. In addition, LPS-treated C57Bl/6 mice showed impaired cardiac mitochondrial function, including reduced respiration and reduced time of induction of permeability transition. All of the aforementioned cardiac dysfunction was dependent on TLR4, because LPS-treated TLR4-deficient mice did not have reduced myocyte contractility or mitochondrial dysfunction. To evaluate the role of cardiac myocyte versus leukocyte TLR4, LPS was injected into chimeric mice with TLR4-positive leukocytes and TLR4-deficient myocytes. These mice showed reduced myocyte contractility in response to LPS. Myocytes from chimeric mice with TLR4-deficient leukocytes and TLR4-positive myocytes had no response to LPS. In addition, isolated myocytes from C57Bl/6 mice subsequently treated with LPS and serum for various times did not have reduced contractility, despite the presence of TLR4 mRNA and protein, as determined by reverse-transcription polymerase chain reaction and fluorescent-activated cell sorting. In fact, cardiac myocytes had equivalent amounts of TLR4 as endothelium; however, only the latter is responsive to LPS. Furthermore, signaling pathways downstream of TLR4 were not activated during direct LPS treatment of myocytes. In conclusion, TLR4 on leukocytes, and not on cardiac myocytes, is important for cardiac myocyte impairment during endotoxemia.


Key words: inflammation • sepsis • neutrophils • heart • contractility




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
S. Blad, A.-K. Welin, I. Kjellmer, K.G. Rosen, and C. Mallard
ECG and Heart Rate Variability Changes in Preterm and Near-Term Fetal Lamb Following LPS Exposure
Reproductive Sciences, July 1, 2008; 15(6): 572 - 583.
[Abstract] [PDF]


Home page
J. Immunol.Home page
Y.-Y. Liu, W.-F. Cai, H.-Z. Yang, B. Cui, Z.-R. Chen, H.-Z. Liu, J. Yan, W. Jin, H.-M. Yan, B.-M. Xin, et al.
Bacillus Calmette-Guerin and TLR4 Agonist Prevent Cardiovascular Hypertrophy and Fibrosis by Regulating Immune Microenvironment
J. Immunol., June 1, 2008; 180(11): 7349 - 7357.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Knuefermann, M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rudiger, O. Boehm, K. Fink, U. Dreiner, C. Grohe, et al.
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9
Cardiovasc Res, April 1, 2008; 78(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cuenca, N. Goren, P. Prieto, P. Martin-Sanz, and L. Bosca
Selective Impairment of Nuclear Factor-{kappa}B-Dependent Gene Transcription in Adult Cardiomyocytes: Relevance for the Regulation of the Inflammatory Response in the Heart
Am. J. Pathol., September 1, 2007; 171(3): 820 - 828.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. H. Boyd, S. Mathur, Y. Wang, R. M. Bateman, and K. R. Walley
Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-{kappa}B dependent inflammatory response
Cardiovasc Res, December 1, 2006; 72(3): 384 - 393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cuenca, P. Martin-Sanz, A. M. Alvarez-Barrientos, L. Bosca, and N. Goren
Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
Am. J. Pathol., November 1, 2006; 169(5): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhu, H. Zhao, A. R. Graveline, E. S. Buys, U. Schmidt, K. D. Bloch, A. Rosenzweig, and W. Chao
MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1900 - H1909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ha, F. Hua, D. Grant, Y. Xia, J. Ma, X. Gao, J. Kelley, D. L. Williams, J. Kalbfleisch, I. W. Browder, et al.
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1910 - H1918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Tavener and P. Kubes
Cellular and molecular mechanisms underlying LPS-associated myocyte impairment
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H800 - H806.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Andonegui, S. M. Kerfoot, K. McNagny, K. V. J. Ebbert, K. D. Patel, and P. Kubes
Platelets express functional Toll-like receptor-4
Blood, October 1, 2005; 106(7): 2417 - 2423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig
Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation
J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005.
[Abstract] [Full Text] [PDF]